P R E M I U M

Novo Nordisk Dances on Lilly’s Experimental Weight-Loss Pill Misses

Thursday, August 7 2025


Eli Lilly’s pill stumbles on efficacy and side effects, pumping Wall Streets love of Novo’s GLP-1.


try moby for free

There's a reason why over 15 million investors love Moby, try for free today